Cargando…

Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review

BACKGROUND: Primary hyperoxaluria (PH) is a rare inborn disorder of the metabolism of glyoxylate, which causes the hallmark production oxalate and forms insoluble calcium oxalate crystals that accumulate in the kidney and other organs. Since the manifestation of PH varies from recurrent nephrolithia...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Ruiming, Lin, Minzhuang, Chen, Zhiyong, Lai, Yongtong, Huang, Xianen, Zhao, Guozhi, Guo, Xuekun, Xiong, Zhongtang, Chen, Juan, Chen, Hui, Jiang, Qingping, Liu, Shaoyan, Yang, Yuexin, Liang, Weixiang, Zou, Minhui, Liu, Tao, Chen, Wenfang, Liu, Hongzhou, Peng, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582561/
https://www.ncbi.nlm.nih.gov/pubmed/31215412
http://dx.doi.org/10.1186/s12882-019-1402-2
Descripción
Sumario:BACKGROUND: Primary hyperoxaluria (PH) is a rare inborn disorder of the metabolism of glyoxylate, which causes the hallmark production oxalate and forms insoluble calcium oxalate crystals that accumulate in the kidney and other organs. Since the manifestation of PH varies from recurrent nephrolithiasis, nephrocalcinosis, and end-stage renal disease with age at onset of symptoms ranging from infancy to the sixth decade, the disease remains undiagnosed until after kidney transplantation in some cases. CASE PRESENTATION: Herein, we report 3 cases of PH diagnosed after kidney transplantation failure, providing the comprehensive clinical course, the ultrasonic image of renal graft and pathologic image of the biopsy, highlighting the relevance of biopsy findings and the results of molecular genetic testing. We also focus on the treatment and the unfavorable outcome of the patients. Meanwhile, we review the literature and show the additional 10 reported cases of PH diagnosed after kidney transplantation. Additionally, we discuss the progressive molecular understanding of the mechanisms involved in PH and molecular therapy. CONCLUSIONS: Overall, the necessity of preoperative screening of PH in all patients even with a minor history of nephrolithiasis and the importance of proper treatment are the lessons we learn from the 3 cases, which prompt us to avoid tragedies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-019-1402-2) contains supplementary material, which is available to authorized users.